| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/01/2006 | CN1740192A Separation and purification procss of neurotoxin and cytotoxin of cobratoxin |
| 03/01/2006 | CN1740191A Plant stress tolerance relevant protein and its coding gene and application |
| 03/01/2006 | CN1740190A Gossypium barbadense lipoid transition protein and its coding gene and application |
| 03/01/2006 | CN1740189A Method of extracting and separating soybean protein |
| 03/01/2006 | CN1739791A Prevention and treatment of hepatocellular cancer |
| 03/01/2006 | CN1739787A Orally administered peptides to ameliorate atherosclerosis |
| 03/01/2006 | CN1243830C Novel mouse CXC chemotactic receptor |
| 03/01/2006 | CN1243770C Neurotrophic growth factor |
| 03/01/2006 | CN1243769C Method for separating and purifying toxin of microcapsule alga |
| 03/01/2006 | CN1243569C Use of active P40 conjugates for nasal delivery |
| 03/01/2006 | CN1243568C Recombination protein for preventing human trachoma bedsnia infestation and its use |
| 02/28/2006 | US7005562 system acquired resistance (SAR) gene expression from arabidopsis; signal transduction; transgenic seeds/plants |
| 02/28/2006 | US7005512 Comprises cytoskeletal protein for use as tool in identification of modulators for diagnosis, prevention and treatment of cardiomyopathies |
| 02/28/2006 | US7005511 Fluorescent protein variants and methods for making same |
| 02/28/2006 | US7005509 Pancreatic expressed chemokines, (PANEC-1); expression vectors, host cells, and diagnostic tests using probes for physiologic or pathologic compromise of the pancreas |
| 02/28/2006 | US7005506 Processing albumin via grinding substance to flour, alkaline and protease extractions, heating, precipitation, neutralization and recovery |
| 02/28/2006 | US7005505 Variants of vascular endothelial cell growth factor |
| 02/28/2006 | US7005501 Interleukins; muteins; diagnostic kits |
| 02/28/2006 | US7005500 Nucleotide sequence coding polypeptide for use in the diagnosis of of neoplastic disorders |
| 02/28/2006 | US7005499 antibodies, fusion proteins and proteins comprising amino acid sequences coded by polynucleotides, used for drug screening prophlaxis of cancer, preclampsia, immune disorders, inflammation, neurological disorders, skin and muscular disorders |
| 02/28/2006 | US7005498 analogues of immunogenic human Her2 proteins comprising amino acid sequences modified foreign T-helper lymphocyte epitopes, used for immunotherapy |
| 02/28/2006 | US7005424 Admininstering mixtures of anticarcinogenic agents and early genes for prophylaxis of cancer, tumors or metastasis; gene expression inhibitors |
| 02/28/2006 | US7005419 Methods for identifying inhibitors of GADD45 polypeptide activity and inhibitors of such activity |
| 02/28/2006 | US7005415 Wherein the DNA synthesis promoting activity of the heparin-binding protein is increased by the covalently bonded sugar chain which can be heparan sulfate; improved in vivo stabilities such as acid resistance and alkali resistance |
| 02/28/2006 | US7005414 Synthetic oxygen transport made from cross-linked modified human or porcine haemoglobin with improved properties, method for a preparation thereof from purified material and use thereof |
| 02/28/2006 | US7005413 Administering an interleukin-1 (IL-1) inhibitor, a Tumor Necrosis Factor (TNF)-alpha inhibitor such as etanercept, and an Osteoprotegerin (OPG) protein of given amino acid sequence; osteoporosis |
| 02/28/2006 | US7005299 gene trap vector containing expression unit of internal ribosome binding site coupled to heterologous gene sequence (antibiotic resistance), for insertion/transformation within mouse embryonic stem cell; homologous recombination |
| 02/28/2006 | US7005296 contains transposon digested with restriction enzyme, green fluorescent protein, promoter region of polyubiquitin gene, nuclear localizing sequence of an SV40 virus, and chaperone proteins; for production of transgenic insects |
| 02/28/2006 | US7005277 Defective adenoviruses and corresponding complementation lines |
| 02/28/2006 | US7005276 missense mutagenesis; blood testing; host cells; kits |
| 02/28/2006 | US7005275 Inducible alphaviral gene expression system |
| 02/28/2006 | US7005271 incubating cell sample with solid phase-bound purified receptor specific for phospholipid, forming immobilized complex, washing, then determining prothrombinase activity |
| 02/28/2006 | US7005270 immunoassay of acidic repeat protein/immunogens; solid phase synthesis; kits for diagnosis of syphilis |
| 02/28/2006 | US7005263 Correcting defective genes by probing the RNA of impaired plants with a nucleic acid comprising at least 50 nucleotide residues of a sequence 90% identical with a specific nucleotide sequence; identifying a plant whose RNA hybridizes with it |
| 02/28/2006 | US7005254 LETM1: modulators of cellular proliferation |
| 02/28/2006 | US7005130 Hepatitis virus for use in the diagnosis and prevention of viral diseases in birds and humans |
| 02/28/2006 | CA2180346C Herpesvirus pre-(viral dna replication) enveloped particles |
| 02/25/2006 | CA2479163A1 Novel leptin antagonist |
| 02/23/2006 | WO2006020931A2 Process for removing endogenous vitamin b12 and folate from albumin preparations |
| 02/23/2006 | WO2006020849A2 Mutant interleukin-15 polypeptides |
| 02/23/2006 | WO2006020717A2 Nucleic acids conferring lipid and sugar alterations in plants ii |
| 02/23/2006 | WO2006020594A2 Cloning and expression of recombinant adhesive protein mefp-1 of the blue mussel, mytilus edulis |
| 02/23/2006 | WO2006020263A2 Cytoxan antibodies and immunoassay |
| 02/23/2006 | WO2006020071A2 Vaccines against aids comprising cmv/r-nucleic acid constructs |
| 02/23/2006 | WO2006019431A2 Methods and kits for measuring adamts13/fxi complexes |
| 02/23/2006 | WO2006018836A2 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
| 02/23/2006 | WO2006018551A1 Novel peptide and pharmaceutical composition containing said peptide |
| 02/23/2006 | WO2006018429A1 Multimers of peptides |
| 02/23/2006 | WO2006018428A2 Hemopexin fusion proteins |
| 02/23/2006 | WO2006018418A2 Antiangiogenic peptides |
| 02/23/2006 | WO2006018049A1 Surface display expression system |
| 02/23/2006 | WO2005123107A3 Immune response suppressor and treatment of multiple sclerosis |
| 02/23/2006 | WO2005116235A9 Endothelial cell apoptosis induced by fibrinogen gamma chain c-terminal fragment |
| 02/23/2006 | WO2005113588A3 Methods and compositions related to smad anchors for tgfb/bmp receptor activaton |
| 02/23/2006 | WO2005111076A8 Nectin 4 (n4) as a marker for cancer prognosis |
| 02/23/2006 | WO2005111069A3 Morphogenic proteins and stimulatory factors in gene therapy |
| 02/23/2006 | WO2005105843A3 Hiv protease inhibitors |
| 02/23/2006 | WO2005103270A8 Nucleotide sequences and polypeptides encoded thereby useful for modifying nitrogen use efficiency characteristics in plants |
| 02/23/2006 | WO2005100575A3 Rice pollen-specific promoters and uses thereof |
| 02/23/2006 | WO2005092362A3 Pharmaceutical combined preparation containing a therapeutic protein |
| 02/23/2006 | WO2005089795A3 Infectious bursal disease virus antigenic isolates and vaccines |
| 02/23/2006 | WO2005064021A3 Vaccine |
| 02/23/2006 | WO2005061538A3 Vaccine comprising an angiomotin or a polynucleotide encoding an angiomotin and its uses for the treatment of angiogenic-related disorders |
| 02/23/2006 | WO2005059546A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 35 (gpr35) |
| 02/23/2006 | WO2005058815A3 Ip-10 antibodies and their uses |
| 02/23/2006 | WO2005057222A3 Use of t-cadherin as a target |
| 02/23/2006 | WO2005056593A3 Interactions between hsp90 and p50/cdc37 |
| 02/23/2006 | WO2005053618A3 Synthetic hla binding peptide analogues and uses thereof |
| 02/23/2006 | WO2005045002A3 Nitrite-oxidizing bacteria and methods of using and detecting the same |
| 02/23/2006 | WO2005030928A3 PORCINE INVARIANT CHAIN PROTEIN, FULL LENGTH cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION |
| 02/23/2006 | WO2005028497A3 Receptor binding peptides derived from the sars s protein |
| 02/23/2006 | WO2005003372A3 Mylks as modifiers of branching morphogenesis and methods of use |
| 02/23/2006 | WO2004108885A3 Fc chimeric proteins with anti-hiv drugs |
| 02/23/2006 | WO2004074310A3 Mycobacterial diagnostics |
| 02/23/2006 | WO2004071464A3 Diagnostic application of differentially-expressed genes in lympho-hematopoietic stem cells |
| 02/23/2006 | WO2004048516A3 Elf3 gene compositions and methods |
| 02/23/2006 | WO2004045553A3 Ca125 gene and its use for diagnostic and therapeutic interventions |
| 02/23/2006 | WO2004043383A3 A new target for angiogenesis and anti-angiogenesis therapy |
| 02/23/2006 | WO2003091690A3 Cancer-associated nucleic acids and polypeptides |
| 02/23/2006 | WO2003086277A9 Attenuated gram negative bacteria |
| 02/23/2006 | WO2003072732A3 Methods of making hypermutable cells using pmsr homologs |
| 02/23/2006 | US20060041962 Genes and uses thereof to modulate secondary metabolite biosynthesis |
| 02/23/2006 | US20060041961 Genes and uses for pant improvement |
| 02/23/2006 | US20060041959 Control of plant growth and developmental process |
| 02/23/2006 | US20060041958 Plant gene |
| 02/23/2006 | US20060041953 Control of fruit dehiscence in Arabidopsis by indehiscenti genes |
| 02/23/2006 | US20060041950 Cassava vein mosaic virus promoters nucleic acid sequences and expression vectors |
| 02/23/2006 | US20060041947 Nessie nucleic acids, polypeptides and mutations, and methods of use thereof |
| 02/23/2006 | US20060041164 liver X receptor LXR agonists; increasing ABCA1, ABCG1, and apolipoprotein E expression, increasing cholesterol efflux from peripheral cells, cardiovascular disease, inflammation; 2-(3-{3-[[2-Chloro-3-(trifluoromethyl)benzyl](2,2-diphenylethyl)amino]-2-methyl-propoxy}-phenyl)acetic acid methyl ester |
| 02/23/2006 | US20060041112 Novel human G-coupled protein receptor kinases and polynucleotides encoding the same |
| 02/23/2006 | US20060041111 Dock 3 tumor suppressor gene |
| 02/23/2006 | US20060041108 Renilla reniformis green fluorescent protein |
| 02/23/2006 | US20060041107 Mutants of streptococcal toxin A and methods of use |
| 02/23/2006 | US20060041106 Apo-3 polypeptide |
| 02/23/2006 | US20060040880 Methods and compositions for treating neuropathic pain |
| 02/23/2006 | US20060040865 Platelet production promoting agent |
| 02/23/2006 | US20060040863 Methods for treatment of diabetes using peptide analogues of insulin |
| 02/23/2006 | US20060040862 XAF genes and polypeptides: methods and reagents for modulating apoptosis |
| 02/23/2006 | US20060040859 Peptides, DNAs, RNAs, and compounds for inhibiting or inducing adrenomedullin activity, and use of the same |
| 02/23/2006 | US20060040858 Novel peptides that bind to the erythropoietin receptor |